<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To investigate first-phase insulin release and peripheral insulin sensitivity of non-<z:mp ids='MP_0001261'>obese</z:mp>, <z:mpath ids='MPATH_458'>normal</z:mpath>-<z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant, first-degree relatives of Chinese type 2 diabetic patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: 12 euglycemic first-degree relatives of type 2 diabetic patients (ERDM), 12 newly diagnosed type 2 diabetic patients (DM-2) and 12 healthy individuals (control) participated in the study </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> subjects were non-<z:mp ids='MP_0001261'>obese</z:mp> (BMI&lt; 25 kg/m(2)) </plain></SENT>
<SENT sid="3" pm="."><plain>Intravenous <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test and euglycemic hyperinsulinemic clamp test were performed to evaluate first-phase insulin release and quantify insulin sensitivity, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: the first-phase insulin release did not differ between the ERDM and control subjects (p=0.532), while the <z:hpo ids='HP_0011009'>acute</z:hpo> insulin response was absent in the DM-2 patients (p=0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>Peripheral <z:chebi fb="105" ids="17234">glucose</z:chebi> deposit rate (GDR) was significantly lower in the ERDM (10.6 ± 2.1mg/kg·min, p=0.000) and DM-2 (9.6 ± 1.1mg/kg·min, p=0.000) groups than that in the control group (13.2 ± 1.2mg/kg·min) </plain></SENT>
<SENT sid="6" pm="."><plain>There was no statistical difference in GDR between the ERDM and DM-2 groups (p=0.110) </plain></SENT>
<SENT sid="7" pm="."><plain>Fasting FFA levels of the ERDM (p=0.007) and DM-2 (p=0.000) subjects were significantly higher than those of the controls </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: non-<z:mp ids='MP_0001261'>obese</z:mp>, first-degree relatives of type 2 diabetic patients with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) exhibit remarkable impairment of insulin sensitivity and <z:mp ids='MP_0001554'>increased FFA levels</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> is independent of <z:hpo ids='HP_0001513'>obesity</z:hpo> and blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level </plain></SENT>
<SENT sid="10" pm="."><plain>Progression from NGT to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> may mainly be attributed to deterioration of early insulin secretion </plain></SENT>
</text></document>